Autopsy report · NCT03509298

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“No participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Fuda Cancer Hospital, Guangzhou
Sponsor type: University, hospital or other
Conditions: Advanced Pancreatic Cancer
Interventions: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer; cryotherapy
Participants: 0
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.